Literature DB >> 24338548

Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.

Cecilia Söderberg-Naucler1, Inti Peredo, Afsar Rahbar, Fredrik Hansson, Anders Nordlund, Giuseppe Stragliotto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24338548     DOI： 10.1002/ijc.28663

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  9 in total

1.  CMV infection and glioma, a highly controversial concept struggling in the clinical arena.

Authors:  Wolfgang Wick; Michael Platten
Journal:  Neuro Oncol       Date:  2014-03       Impact factor: 12.300

Review 2.  Cytomegalovirus and glioblastoma; controversies and opportunities.

Authors:  Sean E Lawler
Journal:  J Neurooncol       Date:  2015-02-15       Impact factor: 4.130

3.  Valganciclovir and bevacizumab for recurrent glioblastoma: A single-institution experience.

Authors:  Chengwei Peng; Jialing Wang; Jarred P Tanksley; Bret C Mobley; Gregory D Ayers; Paul L Moots; Stephen W Clark
Journal:  Mol Clin Oncol       Date:  2015-12-04

Review 4.  The Viral Connection to Glioblastoma.

Authors:  J Ricardo McFaline-Figueroa; Patrick Y Wen
Journal:  Curr Infect Dis Rep       Date:  2017-02       Impact factor: 3.725

Review 5.  The role of CMV in glioblastoma and implications for immunotherapeutic strategies.

Authors:  Maryam Rahman; Farhad Dastmalchi; Aida Karachi; Duane Mitchell
Journal:  Oncoimmunology       Date:  2018-10-16       Impact factor: 8.110

6.  Glioblastoma Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series and Literature Review.

Authors:  Keenan Piper; Haidn Foster; Brandon Gabel; Burt Nabors; Charles Cobbs
Journal:  Front Oncol       Date:  2019-01-22       Impact factor: 6.244

7.  Human cytomegalovirus seropositivity is associated with decreased survival in glioblastoma patients.

Authors:  Haidn Foster; Keenan Piper; Lisa DePledge; Hsin-Fang Li; James Scanlan; Yoon Jae-Guen; Michael Boeckh; Charles Cobbs
Journal:  Neurooncol Adv       Date:  2019-09-07

Review 8.  Cytomegalovirus in Haematological Tumours.

Authors:  Sara Alonso-Álvarez; Enrique Colado; Marco A Moro-García; Rebeca Alonso-Arias
Journal:  Front Immunol       Date:  2021-10-18       Impact factor: 7.561

Review 9.  Cytomegalovirus and Glioblastoma: A Review of the Biological Associations and Therapeutic Strategies.

Authors:  Tianrui Yang; Delin Liu; Shiyuan Fang; Wenbin Ma; Yu Wang
Journal:  J Clin Med       Date:  2022-09-04       Impact factor: 4.964
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.